1. Home
  2. MIR vs BLCO Comparison

MIR vs BLCO Comparison

Compare MIR & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mirion Technologies Inc.

MIR

Mirion Technologies Inc.

N/A

Current Price

$21.67

Market Cap

6.2B

Sector

Technology

ML Signal

N/A

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

N/A

Current Price

$17.46

Market Cap

6.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MIR
BLCO
Founded
2005
1853
Country
United States
Canada
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Ophthalmic Goods
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.2B
6.0B
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
MIR
BLCO
Price
$21.67
$17.46
Analyst Decision
Strong Buy
Buy
Analyst Count
8
12
Target Price
$27.88
$18.55
AVG Volume (30 Days)
3.5M
438.6K
Earning Date
01-01-0001
05-21-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$5,101,000,000.00
Revenue This Year
$24.05
$8.61
Revenue Next Year
$7.40
$5.52
P/E Ratio
$195.00
N/A
Revenue Growth
N/A
6.47
52 Week Low
$12.00
$10.45
52 Week High
$30.28
$18.92

Technical Indicators

Market Signals
Indicator
MIR
BLCO
Relative Strength Index (RSI) 45.09 48.74
Support Level $19.76 $16.35
Resistance Level $22.49 $17.66
Average True Range (ATR) 0.81 0.49
MACD 0.12 -0.12
Stochastic Oscillator 63.70 31.12

Price Performance

Historical Comparison
MIR
BLCO

About MIR Mirion Technologies Inc.

Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: